Study of Drug Susceptibility, Resistance Patterns and Mutations, in Patients Diagnosed with Drug Resistant Tuberculosis in a Tertiary Care Centre Aurangabad, Maharashtra
International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)
DOI: 10.25258/ijcpr.18.4.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von Akash Bhardwaj und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Drug-resistant tuberculosis (DR-TB) remains a major public health challenge, particularly in high-burden countries like India. Resistance to first-line anti-tubercular drugs complicates treatment and contributes to increased morbidity and mortality. Understanding drug susceptibility patterns and associated genetic mutations is essential for effective management and control of DR-TB.
Methods
A prospective observational study was conducted over a period of two years at MGM Medical College and Hospital, Aurangabad, Maharashtra. A total of 82 patients diagnosed with drug-resistant tuberculosis were enrolled, of which 80 patients with complete data were included in the final analysis. Drug susceptibility testing and mutation analysis were performed for first- and second-line anti-tubercular drugs. Data were analyzed using R software (version 4.3.2). Demographic characteristics, clinical profile, resistance patterns, and associated mutations were assessed.
Results
Among the 80 patients studied, the majority belonged to the 10–30 years age group (51.25%), and males constituted 63.75% of cases. Most patients (93.75%) had no prior history of tuberculosis. Pulmonary tuberculosis was the predominant presentation (83.75%), while extrapulmonary disease accounted for 16.25%. Isoniazid resistance was observed in 96.25% of patients, with mutations in katG (79.22%) and inhA (28.57%). Rifampicin resistance associated with rpoB mutation was identified in 38.75% of patients. Fluoroquinolone resistance was seen in 23.75% of cases, predominantly involving gyrA mutation (100%) and gyrB mutation (63.16%). Resistance to second-line injectable drugs was identified in 5% of patients, associated with rrs and eis mutations. Pyrazinamide resistance was rare (1.25%).
Conclusion
The study demonstrates a high burden of drug-resistant tuberculosis among young adults, with significant resistance to first-line drugs and identifiable genetic mutations. Routine drug susceptibility testing and molecular diagnostics are essential for early detection and effective management of DR-TB.
Zitieren
APA
Bhardwaj, A., Prakash, A., Jadhav, S., Deshmukh, A. S., Deshmukh, H., & Kasat, S. (2026). Study of Drug Susceptibility, Resistance Patterns and Mutations, in Patients Diagnosed with Drug Resistant Tuberculosis in a Tertiary Care Centre Aurangabad, Maharashtra. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.9
Vancouver
Bhardwaj A, Prakash A, Jadhav S, Deshmukh AS, Deshmukh H, Kasat S. Study of Drug Susceptibility, Resistance Patterns and Mutations, in Patients Diagnosed with Drug Resistant Tuberculosis in a Tertiary Care Centre Aurangabad, Maharashtra. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.9
BibTeX
@article{Bhardwaj2026,
author = {Bhardwaj, Akash and Prakash, Anupam and Jadhav, Sunil and Deshmukh, Ashish S. and Deshmukh, Hafiz and Kasat, Shivprasad},
title = {Study of Drug Susceptibility, Resistance Patterns and Mutations, in Patients Diagnosed with Drug Resistant Tuberculosis in a Tertiary Care Centre Aurangabad, Maharashtra},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {04},
doi = {10.25258/ijcpr.18.4.9}
}
EUVIMED